{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:29Z","timestamp":1786120349683,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/ico.0b013e31823f8e7d","type":"journal-article","created":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T20:31:29Z","timestamp":1331238689000},"page":"1229-1234","source":"Crossref","is-referenced-by-count":67,"title":["Comparison of the Long-Term Effects of Various Topical Antiglaucoma Medications on Meibomian Glands"],"prefix":"10.1097","volume":"31","author":[{"given":"Reiko","family":"Arita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouzo","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Tomidokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210204","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0161-6420(92)31847-0","article-title":". Ocular surface alteration after long-term treatment with an antiglaucomatous drug.","volume":"99","author":"Herreras","year":"1992","journal-title":"Ophthalmology"},{"key":"R2-3-20210204","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1442-9071.2000.00237.x","article-title":". Adverse effects of topical antiglaucoma drugs on the ocular surface.","volume":"28","author":"Arici","year":"2000","journal-title":"Clin Exp Ophthalmol"},{"key":"R3-3-20210204","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1034\/j.1600-0420.2000.078001037.x","article-title":". Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertension.","volume":"8","author":"Thygesen","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"R4-3-20210204","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","article-title":"A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.","volume":"103","author":"Watson","year":"1996","journal-title":"Ophthalmology"},{"key":"R5-3-20210204","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","article-title":"Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.","volume":"103","author":"Camras","year":"1996","journal-title":"Ophthalmology"},{"key":"R6-3-20210204","first-page":"3442","article-title":". Basal tear turnover and topical timolol in glaucoma patients and healthy controls by fluorophotometry.","volume":"33","author":"Kuppens","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-3-20210204","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0002-9394(79)90675-5","article-title":"Corneal anesthesia after timolol maleate therapy.","volume":"88","author":"Van Buskirk","year":"1979","journal-title":"Am J Ophthalmol"},{"key":"R8-3-20210204","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0161-6420(80)35215-9","article-title":"Adverse reactions from timolol administration.","volume":"87","author":"Van Buskirk","year":"1980","journal-title":"Ophthalmology"},{"key":"R9-3-20210204","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0161-6420(80)35214-7","article-title":"The place of timolol in the practice of ophthalmology.","volume":"87","author":"Wilson","year":"1980","journal-title":"Ophthalmology"},{"key":"R10-3-20210204","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","article-title":"Effects on intraocular pressure and side effects of 0.005 latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.","volume":"102","author":"Alm","year":"1995","journal-title":"Ophthalmology"},{"key":"R11-3-20210204","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0161-6420(89)32888-0","article-title":". Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenons capsule in glaucoma patients.","volume":"96","author":"Sherwood","year":"1989","journal-title":"Ophthalmology"},{"key":"R12-3-20210204","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9394(14)76730-3","article-title":". Conjunctival impression cytology in patients with glaucoma using long-term topical medication.","volume":"112","author":"Brandt","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"R13-3-20210204","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0161-6420(94)31322-4","article-title":". Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma.","volume":"101","author":"Baudouin","year":"1994","journal-title":"Ophthalmology"},{"key":"R14-3-20210204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ophtha.2007.01.036","article-title":". The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways.","volume":"115","author":"Baudouin","year":"2008","journal-title":"Ophthalmology"},{"key":"R15-3-20210204","first-page":"308","article-title":"Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas.","volume":"19","author":"Burstein","year":"1980","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-3-20210204","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/bjo.82.1.39","article-title":"Short-term comparative study of topical 2 carteolol with and without benzalkonium chloride in healthy volunteers.","volume":"82","author":"Baudouin","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"R17-3-20210204","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1755-3768.1977.tb06092.x","article-title":"Effects of ophthalmic vehicles on the stability of the precorneal film.","volume":"55","author":"Norm","year":"1977","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R18-3-20210204","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0420.1995.tb00277.x","article-title":". Effects of antiglaucoma drugs on ocular surface.","volume":"73","author":"Yalvac","year":"1995","journal-title":"Acta Ophthalmol Scand"},{"key":"R19-3-20210204","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9394(14)73757-2","article-title":". Decreased basal tear turnover in patients with untreated primary open-angle glaucoma.","volume":"120","author":"Kuppens","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"R20-3-20210204","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bjo.79.4.339","article-title":". Effect of timolol with and without preservative on the basal tear turnover in glaucoma.","volume":"79","author":"Kuppens","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"R21-3-20210204","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00061198-200312000-00008","article-title":"Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride.","volume":"12","author":"Ishibashi","year":"2003","journal-title":"J Glaucoma"},{"issue":"pt 4","key":"R22-3-20210204","first-page":"402","article-title":"The effects of topical drugs and preservatives on the tears and corneal epithelium in dry eye.","volume":"104","author":"Burstein","year":"1985","journal-title":"Trans Ophthalmol Soc U K"},{"key":"R23-3-20210204","first-page":"619","article-title":". Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells.","volume":"40","author":"De Saint Jean","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R24-3-20210204","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1076\/0271-3683(200002)2021-DFT085","article-title":". Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells.","volume":"20","author":"De Saint Jean","year":"2000","journal-title":"Curr Eye Res"},{"key":"R25-3-20210204","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":". The international workshop on meibomian gland dysfunction: executive summary.","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-3-20210204","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ophtha.2007.06.031","article-title":". Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population.","volume":"115","author":"Arita","year":"2008","journal-title":"Ophthalmology"},{"key":"R27-3-20210204","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1167\/iovs.10-6997e","article-title":". The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated factors for, MGD.","volume":"52","author":"Schaumberg","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R28-3-20210204","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.ophtha.2009.04.037","article-title":". Proposed diagnostic criteria for obstructive meibomian gland dysfunction.","volume":"116","author":"Arita","year":"2009","journal-title":"Ophthalmology"},{"key":"R29-3-20210204","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0161-6420(98)98033-2","article-title":". Meibomian gland dysfunction in patients with Sjogren Syndrome.","volume":"105","author":"Shimazaki","year":"1998","journal-title":"Ophthalmology"},{"key":"R30-3-20210204","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients.","volume":"17","author":"Leung","year":"2008","journal-title":"J Glaucoma"},{"key":"R31-3-20210204","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00061198-200312000-00007","article-title":". Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy.","volume":"12","author":"Inoue","year":"2003","journal-title":"J Glaucoma"},{"key":"R32-3-20210204","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1001\/archopht.1994.01090230051020","article-title":". Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile.","volume":"112","author":"Broadway","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R33-3-20210204","first-page":"537","article-title":"Meibomian gland studies: histologic and ultrastructural investigations.","volume":"20","author":"Jester","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R34-3-20210204","first-page":"946","article-title":". Meibomian gland dysfunction, III. Meibomian gland lipids.","volume":"30","author":"Nicolaides","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R35-3-20210204","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/ICO.0b013e3181ca3668","article-title":". Meibomian gland duct distortion in patients with perennial allergic conjunctivitis.","volume":"29","author":"Arita","year":"2010","journal-title":"Cornea"},{"key":"R36-3-20210204","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bjo.59.11.667","article-title":"Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man.","volume":"59","author":"Wilson","year":"1975","journal-title":"Br J Ophthalmol"},{"key":"R37-3-20210204","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1167\/iovs.08-2992","article-title":". Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage.","volume":"50","author":"Pauly","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ICO.0b013e31823f8e7d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:35:36Z","timestamp":1786048536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-201211000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31823f8e7d","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}